Impact of radiofrequency catheter ablation for atrial fibrillation in patients with left atrial enlargement

Kohei Ukita,Yasuyuki Egami,Akito Kawamura,Hitoshi Nakamura,Yutaka Matsuhiro,Koji Yasumoto,Masaki Tsuda,Naotaka Okamoto,Yasuharu Matsunaga-Lee,Masamichi Yano,Masami Nishino,Jun Tanouchi
DOI: https://doi.org/10.1007/s00380-022-02094-z
2022-05-15
Heart and Vessels
Abstract:Little has been reported on the impact of radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) in patients with left atrial enlargement (LAE). A total of 706 patients underwent an initial RFCA for AF between September 2014 and September 2019 in our hospital. These patients were categorized into two groups according to the pre-procedural left atrial diameter (LAD) measured by transthoracic echocardiography (TTE): LAE group with LAD ≥ 50 mm and non-LAE group with LAD < 50 mm. We compared the patient characteristics, ablation procedures, and late recurrence of AF (LRAF, defined as a recurrence of atrial tachyarrhythmia between 3 and 12 months after the RFCA) between the two groups. In addition, we performed follow-up TTE at 12 months after RFCA and investigated the factors associated with left atrium (LA) reverse remodeling in each group. LAE group and non-LAE group consisted of 155 and 551 patients, respectively. There were no significant differences in ablation procedures, procedure-related complications, and the incidence of LRAF between the two groups. Furthermore, non-PAF was identified as an independent predictor of LA reverse remodeling in LAE group by multiple regression analysis ( P = 0.020). RFCA might be an effective and safe procedure even in patients with LAD ≥ 50 mm, using the contemporary 3D-guided mapping and ablation technologies. Moreover, RFCA can lead to LA reverse remodeling in 1 year if they have non-PAF before ablation.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?